Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Auto Casualty
News Release
AM Best TV: Interview With Michele Hibbert-Iacobacci About Michigan No-Fault Reform
Mitchell Senior Vice President of Regulatory Compliance Management Michele-Hibbert Iacobacci explains the new Michigan no-fault law, including the
Workers' Comp
Blog
Not all victims of workplace trauma sustain physical injuries
Nearly two million Americans experience violence in the workplace annually.1 According to the National Center for Victims of Crime, work
Workers' Comp
Virtual Event
Medical Marijuana: Comparing and Contrasting Clinical and Legislative Insights
On-Demand
As many states move to legalize medical and recreational marijuana, what do you need to know about its potential clinical benefits and uses, along
Workers' Comp
Virtual Event
Changing Consumer Expectations: What Workers' Compensation Can Learn from the Healthcare Industry
On-Demand
Workers' Comp
Virtual Event
Beyond Opioids: Current Alternatives for Pain Management [Podcast]
On-Demand
The discussion of alternatives to opioids continues as the workers’ compensation industry works to find ways to treat and manage pain.
Workers' Comp
Virtual Event
The Gig Economy and Workers' Compensation [Podcast]
On-Demand
We sat down with Ira Goldstein, Executive Director of The Black Car Fund